A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants with Asthma

Trial Identifier: D6935C00002
Sponsor: AstraZeneca
Start Date: February 2025
Primary Completion Date: October 2025
Study Completion Date: October 2025
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA Encinitas, CA, US, 92024
US, CA Los Angeles, CA, US, 90048
US, CA Los Angeles, CA, US, 90025
US, CA Newport Beach, CA, US, 92663
US, CA San Diego, CA, US, 92123
US, CA San Jose, CA, US, 95117
US, CA Stockton, CA, US, 95207
US, FL Clearwater, FL, US, 33765
US, FL Miami, FL, US, 33175
US, FL Tallahassee, FL, US, 32308
US, FL Tampa, FL, US, 33607
US, MD White Marsh, MD, US, 21162
US, MO Columbia, MO, US, 65203
US, MO Saint Charles, MO, US, 63301
US, MO Saint Louis, MO, US, 63141
US, MO St Louis, MO, US, 63141
US, NC Raleigh, NC, US, 27607
US, OR Medford, OR, US, 97504
US, OR Portland, OR, US, 97202
US, SC North Charleston, SC, US, 29420
US, TX Austin, TX, US, 78759
US, TX El Paso, TX, US, 79903
US, TX San Antonio, TX, US, 78229
US, TX Victoria, TX, US, 77901
US, WI Milwaukee, WI, US, 53228